Lineage Cell Therapeutics (LCTX) Capital Expenditures (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.92% |
| Dec 31, 2025 | 677.91% |
| Sep 30, 2025 | -714.29% |
| Jun 30, 2025 | -85.57% |
| Mar 31, 2025 | -73.42% |
| Dec 31, 2024 | 157.04% |
| Sep 30, 2024 | 610.00% |
| Jun 30, 2024 | -47.37% |
| Mar 31, 2024 | -94.29% |
| Dec 31, 2023 | 252.75% |
| Sep 30, 2023 | -270.31% |
| Jun 30, 2023 | 36.17% |
| Mar 31, 2023 | 146.88% |
| Dec 31, 2022 | -240.21% |
| Sep 30, 2022 | 194.85% |
| Jun 30, 2022 | 110.87% |
| Mar 31, 2022 | -68.49% |
| Dec 31, 2021 | 170.37% |
| Sep 30, 2021 | -58.14% |
| Jun 30, 2021 | 1,072.73% |